FORT MYERS, Fla, Oct. 19 /PRNewswire-FirstCall/ -- Radiation Therapy Services, Inc. , a leading operator of radiation therapy centers, announced today that it has closed on the previously announced definitive purchase agreement for a third radiation treatment center in New Jersey. Radiation Therapy has received license transfer approval on the facility, located adjacent to Lady of Lourdes in Willingboro. With the completion of this acquisition, the center will operate under the 21st Century Oncology brand.
Dr. Daniel Dosoretz, President and Chief Executive Officer, stated, “We have completed the acquisitions of three centers in New Jersey and have established our 18th regional network. We will upgrade these facilities with advanced technologies and expect to implement an Intensity Modulated Radiation Therapy (IMRT) program as part of our regional network strategy. We are continuing to evaluate acquisition opportunities in growth markets.”
About Radiation Therapy Services
Radiation Therapy Services, Inc., which operates treatment centers primarily under the name 21st Century Oncology, is a provider of radiation therapy services to cancer patients. The Company’s 55 treatment centers are clustered into 18 regional networks in nine states, including Alabama, Delaware, Florida, Kentucky, Maryland, Nevada, New Jersey, New York and North Carolina. The Company is headquartered in Fort Myers, Florida. More information about the Company can be found at its Web site http://www.rtsx.com/.
This release contains forward-looking statements about the Company’s future plans, expectations and objectives. Words such as “may,” “will,” “expect,” “intend,” “anticipate,” “plan,” “believe,” “seek,” “could” and “estimate” and variations of these words and similar expressions are intended to identify forward-looking statements. These forward-looking statements are not historical facts and are subject to risks and uncertainties that could cause the actual results to differ materially from those projected in these forward-looking statements including, but not limited to, the Company’s ability to consummate the proposed acquisition, the integration and future performance of the treatment centers to be acquired and those risk factors described in the Company’s recent quarterly report on Form 10-Q and the “Risk Factors” section of the Form S-1 Registration Statement, as amended, relating to the Company’s initial public offering as well as the Company’s other filings with the Securities and Exchange Commission which are available on the SEC’s website at http://www.sec.gov/. Readers of this release are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to publicly update or revise the forward-looking statements contained herein to reflect changed events or circumstances after the date of this release.
Contacts: Investors/Media: Dave Koeninger Stephanie Carrington/Greg Tiberend Chief Financial Officer The Ruth Group Radiation Therapy Services, Inc. 646-536-7008/7005 239-931-7282 scarrington@theruthgroup.comdkoeninger@rtsx.comgtiberend@theruthgroup.com
Radiation Therapy Services, Inc.
CONTACT: Dave Koeninger, Chief Financial Officer of Radiation TherapyServices, Inc, +1-239-931-7282, or dkoeninger@rtsx.com; or Investors andMedia, Stephanie Carrington, +1-646-536-7008, or scarrington@theruthgroup.com,or Greg Tiberend, +1-646-536-7005, or gtiberend@theruthgroup.com, both of TheRuth Group, both for Radiation Therapy Services, Inc.
Web site: http://www.rtsx.com/